K Szepeshazi

Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.

A. Schally, K. Szepesházi, A V Schally, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

M Kovacs, A. Schally, K. Groot, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.

J. Isaacs, A. Schally, K. Szepesházi, 1992, Cancer research.